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Abstract 
Introduction: The aim of the study was to determine the effect of long-term
cyclosporine A (CsA) treatment in children with idiopathic nephrotic syndrome on
autonomic nerve function and peripheral blood flow assessed with thermography.
Material and methods: The study group consisted of 19 nephrotic children
treated with cyclosporine A compared to 16 healthy children. The assessment
of blood flow was made based on the results of thermographic measurements
during the cold stress test by an infrared radiation registering camera. Ewing’s
battery of non-invasive tests was used to assess autonomic function. 
Results: The study showed diminished temperature increase after the cooling
test in children with nephrotic syndrome treated with CsA. Sympathetic activity
test results were comparable to healthy children. 
Conclusions: It may be hypothesized that cyclosporine A administered even in
low doses induces small vessel dysfunction measured by the thermographic
method. This effect seems to be independent of sympathetic nervous system
involvement, which was absent in cyclosporine A treated nephrotic children.
Key words: cyclosporine A, autonomic function, vasodilatation, thermography,
children, nephrotic syndrome.
Introduction
Cyclosporine A (CsA) is used routinely in the immunosuppressive regimen
in children with both steroid-dependent and steroid-resistant nephrotic
syndrome (SD-NS and SR-NS) [1-3]. However, its use is limited by adverse
reactions, which include acute and chronic nephrotoxicity and hypertension
[4, 5]. Mechanisms by which CsA treatment leads to nephrotoxicity and
hypertension are poorly understood. It has been shown that acute dose-
dependent CsA nephrotoxicity results from functional vasoconstriction of
the afferent pre-glomerular arterioles followed by a decrease in renal blood
flow [6]. Prolonged vasoconstriction causing chronic ischaemia may
contribute to chronic CsA-dependent tubulointerstitial changes [4, 5, 7, 8].
The concept of CsA inducing hypertension through impairment of vascular
regulatory mechanisms is still under debate. 
Acute CsA-dependent impairment of peripheral blood flow presenting
as Raynaud’s phenomenon (RP) has recently been described by Arinsoy et
al. and Sharma et al. [9, 10]. Raynaud’s phenomenon is a symptom of
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cutaneous microvascular lesion related to disturbed
local and/or systemic regulation of skin
microcirculation. Blood flow in the microcirculation
is controlled by three major elements: vascular
smooth muscle cell tone, endothelial function and
sympathetic innervation [11]. Cyclosporine A use was
found to affect sympathetic nervous system activity
as well as endothelial function [5, 7, 12, 13]. Since
sympathetic nerve activity is a major determinant
of vascular tone, peripheral vascular function
assessment should include measurements of both
vascular reactivity and sympathetic activity [11]. To
fully investigate the direct effect of CsA on these
parameters the potential influence of administration
of additional drugs should be excluded. However,
steroids are used very frequently with CsA and
complete removal should be avoided.
The aim of the study was to determine the effect
of long-term CsA treatment in children with
idiopathic nephrotic syndrome on peripheral blood
flow as assessed with thermography and autonomic
nerve function.
Material and methods
Subjects
The study group consisted of 19 children (11 M,
8 F; mean age 10.8 ±4.4 years) with mean duration
of nephrotic syndrome 6.3 ±4.1 years. All subjects
from the study group were treated with CsA for at
least 6 months, mean 44.5 ±27.6 months. Other
medication included prednisone (30% of patients,
mean dose 0.5 mg/kg/day). Five patients in the
study group were hypertensive and they were all
treated with angiotensin-converting enzyme (ACE)
inhibitors in monotherapy. Subjects with cardio  -
vascular disease other than hypertension, postural
hypotension, hypo- or hyperthyroidism, and inter  -
current infection were excluded from the study. 
All patients were in the remission of nephrotic
syndrome defined by normal plasma albumin level
with no proteinuria when the study procedures
were performed. 
Sixteen healthy age- and gender-matched
children served as controls. The clinical charac  te  -
ristics of the groups are presented in Table I.
Procedures
Thermographic imaging
Vascular function studies were carried out in the
morning after a 12-h fast. The assessment of blood
flow was made based on the results of
thermographic measurements during the cold stress
test (CST). The infrared radiation registering device
Inframetrics PM290 camera (Inframetrics Corp.,
Billerica, Mass., USA) was used for registration. Data
acquisition and analysis were conducted using
software prepared by the Institute of Electronics,
Technical University of Lodz [14]. The software was
used to calculate mean temperature in the
predefined skin areas and temperature time trend
projections, thus enabling precise temperature
change assessment in various parts of the body. 
The thermographic assessment was performed
according to the method described by Ammer and
Ring [14]. In short, a standard thermogram of the
dorsal surface of both hands was recorded after 
15-min equilibration in a draught-free room at
a controlled temperature of 22°C. The hands were
then placed on a thin board at heart level. The CST
was performed by covering the hands with gloves
and immersing them into a large bowl of water at
20°C for 1 min. Afterwards the temperature of both
hands was recorded by infrared camera every 10 s for
10 min. The metacarpal region and finger region were
predefined for the purpose of temperature change
assessment. Temperature recorded in the finger
region was the mean for five fingers. 
Peripheral blood flow disturbances were
assessed with dynamic temperature changes
registration and characterized as the temperature
increase rate in the first 5 min after CST.
A gradient between the finger and metacarpal
regions greater than 4°C after 10 min of CST was con  -
sidered diagnostic for RP [15]. 
Table I. Selected clinical data from the cyclosporine A
treated and healthy children
* significantly different vs. controls p < 0.05
Data Study group Controls
Number of patients 19 16
Male/female 11/8 10/6
Age [years] 10.8 ±4.4 11.7 ±3.8
BMI [kg/m2] 20.9 ±5.5 18.5 ±2.6
Systolic blood pressure [mmHg] 118 ±11* 112 ±3
Diastolic blood pressure [mmHg] 75 ±6* 71 ±3
NS treatment [months] 75.6 ±49.2 –
eGFR [ml/min/1.73 m BSA] 128 135
CsA treatment [months] 44.5 ±27.6 –
Mean CsA [ng/ml] 70.9 ±47.0 –
Haemoglobin [g/l] 133 ±9 136 ±11
Albumin [g/l] 33 ±4 35 ±5
Response to steroid therapy:
• steroid dependency 18 –
• steroid resistance 1
Histology at onset of NS:
• MCD 18 –
• FSGS 1
Nephrotoxicity on renal  2 –
biopsy [patients]
Hypertension [patients] 5* 0*Arch Med Sci 4, August / 2010 575
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Basic biochemistry
Blood for biochemical assays was sampled in
fasting conditions upon completion of vascular
studies. Plasma was separated instantly at 4°C in
a refrigerated centrifuge. In both groups serum
creatinine, albumin, haemoglobin, cholesterol 
and urinary protein level were assessed using
standard laboratory methods. Plasma creatinine
concentration was used to estimate creatinine
clearance according to the Schwartz formula. Whole
blood CsA level was assessed using a non-specific
radioimmunoassay. 
Autonomic function testing 
Cardiovascular autonomic function was assessed
on the same day at least 2 h after the subjects 
had their meal. The following Ewing’s battery of
non-invasive tests was used [15]:
1. Blood pressure reaction to standing (orthostatic
hypotension test). Blood pressure was recorded
after 10 min of supine rest and after 2 min in the
standing position. Reduction of minimum 20 mmHg
in systolic and minimum 10 mmHg in diastolic
pressure after standing up was considered
diagnostic for orthostatic hypotension.
2. Heart rate response (HRR) to standing (30 : 15
ratio). The ECG monitoring was performed after
a rest period in the supine position of 10 min,
starting from 1 min before until 30 s after standing.
The ECG tracings were used to determine the 
30 : 15 ratio calculated as the ratio of the longest
R-R interval found at about beat 30 to the shortest
R-R interval found at about beat 15. 
3. Valsalva manoeuvre. The ECG monitoring was
performed while the patient in supine position
forcibly exhaled for 15 s against a fixed resistance
(40 mmHg) with open glottis. The ratio of the
longest R-R interval after the manoeuvre to the
shortest R-R interval during or shortly after the
manoeuvre was calculated, and a ratio equal to
or lower than 1.1 was considered abnormal. 
4. Deep breathing test. The ECG monitoring was
performed in supine position with the patient
breathing deeply at a rate of 6 breaths/min. An
average of 6 cycles was taken and the maximum
(during inspiration) heart rate minus the
minimum (during expiration) heart rate was
calculated. The average difference found for 
6 consecutive inspiration-expiration cycles was
taken as the final result, with a value equal to or
lower than 10 bpm considered abnormal.
Statistical analysis
Statistical analysis was performed using the
STATISTICA for Windows software package
(version 5.5 PL, #AXXP0105488425A55, StatSoft,
Tulsa, Ohio, USA). For all analysed continuous
parameters that showed a normal distribution (as
confirmed with Kolmogorov and Lilliefors tests),
differences between means were assessed by the
Student’s t-test for unpaired data. Differences in
distribution were analysed by the non-parametric
χ2 test, when necessary with Yates’ correction.
The measurements were expressed as means 
(± SD). Values for p < 0.05 were considered signi  f  -
icant.
The study received approval from the local
independent Ethics Review Board. Informed written
consent was obtained (after careful explanation)
from parents or caregivers and children when
applicable (over 15 years).
Results
Finger region temperature increase within 5 min
following CST was significantly diminished in
children with nephrotic syndrome treated with CsA
than in the control group (0.26 ±0.26 and 0.51
±0.29°C/min, p = 0.02), while metacarpal region
temperature change was similar in both groups.
Temperature in both predefined hand regions 5 min
after CST was stable in both groups.
Raynaud’s phenomenon was found in three
children (2 girls and 1 boy) from the study group
and in 2 girls from the control group 
(p > 0.05). Not unexpectedly, the temperature
gradient between finger and metacarpal regions
after CST in patients with RP was 4.81 ±0.24, while
in study group subjects without RP it was 
0.58 ±0.37 (p < 0.01). The temperature change after
CST was similar in subjects with and without
hypertension (0.19 ±0.18 vs. 0.38 ±0.36°C/min,
respectively; p = 0.23).
No significant differences in autonomic function
tests were found between study and control groups.
In detail, the test results were: Orthostatic
hypotension test was positive for 4 patients in the
study and 3 subjects in the control group (p = 0.79).
The mean slope of blood pressure did not differ
significantly (systolic: 15 ±5 vs. 13 ±3 mm Hg;
diastolic 7 ±3 vs. 8 ±2 mmHg, p : 0.05). The results
of HRR test 30 : 15 index (1.24 ±0.19 vs. 1.33 ±0.2),
Valsalva manoeuvre (1.59 ±0.35 vs. 1.84 ±0.53) and
E : I index (1.46 ±0.24 vs. 1.45 ±0.17) were also not
different; all p > 0.05.
The mean dose of CsA was 4.3 ±1.6 mg/kg. At
the time of the study mean plasma CsA in the study
group was 70.9 ±26.0 ng/ml, with concentration
from the 6-month period before the study 
85.7 ±40.1 ng/ml. No statistically significant
correlation between CsA or steroid treatment
duration or dose and temperature change after CST
was found. Similarly, no correlation between plasma
CsA and biochemical parameters or hand warming
indices was noted either. Results of laboratory
measurements are summarized in Table I.576 Arch Med Sci 4, August / 2010
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Discussion
Impaired endothelial function has been
postulated as a link between accelerated
atherosclerosis and NS [16, 17]. Children with 
NS are known to present with vascular com  -
plications much more often than the general
population. Interestingly, there have been no studies
assessing the peripheral circulation in NS; however,
it was found that sympathetic hyperreactivity often
accompanies proteinuric renal diseases [18]. The
defective baroreflex control over renal sympathetic
nerves might also be related to impaired renal
sodium handling [18, 19]. Amongst the wide range
of drugs prescribed in NS only CsA has been
reported to directly influence endothelium and
sympathetic activity and raise blood pressure by
these pathways [5, 12].
In our study, the rate of temperature change in
fingers after CST was significantly lower in NS
patients treated with CsA than in healthy children,
which suggests that the peripheral circulation is
impaired in this group of subjects. 
The microcirculation damage in the study group
was not severe enough to increase prevalence of
RP, a symptom of significant vascular regulation
impairment [20, 21]. This may result from either the
young age of the patients or relatively low doses of
CsA used due to its toxicity. Sharma et al. reported
a case of a post-renal transplant patient in whom
RP always occurred at the time of CsA dose increase
and when plasma CsA concentration exceeded 
300 ng/ml. Dose reduction and plasma CsA below
200 ng/ml led to RP resolution [10].
Static measurements of temperature distribution
cannot serve as an objective examination as they
considerably depend on the temperature of the
surroundings. That was the reason why we applied
a dynamic method of constant temperature
registration after cooling the hands that detects
even small but significant disturbances of blood
flow.
Apart from the destructive effect of NS on
vasculature, CsA treatment may additionally distort
vascular regulation. Lucini et al. and Stein et al.
reported similar findings in patients treated with
CsA after heart transplantation and with
rheumatoid arthritis [5, 22]. Stein et al. found that
CsA directly impaired vascular vasodilation through
endothelium-related pathways rather than affecting
nervous regulation [22]. 
Both sympathetic and parasympathetic parts of
the autonomic nervous system are involved in
vascular regulation. Ewing’s battery has long been
used as a reliable tool for autonomic nervous
function assessment. Heart rate variability with
deep breathing, heart rate response to Valsalva
manoeuvre and heart rate response to standing 
(30 : 15 ratio) verify mostly parasympathetic
function, and blood pressure response to standing
assesses sympathetic adrenergic function [11].
However, no relation between autonomic nervous
system activity and microcirculation impairment in
NS children was found. Both NS and CsA treatment
may exert an effect on peripheral nerves, but in NS
patients only the intrarenal sympathetic nervous
system function was disturbed and was closely
related to the renal sodium handling [8, 18, 23].
A distinct influence of CsA on renal and extrarenal
small vessel reactivity was observed in transplanted
rats by Gabriëls et al. [24].
Previous studies have reported on CsA-related
neurotoxicity within the autonomic nervous system,
while in contrast a recent publication questioned
the role of increased sympathetic activity in the
CsA-induced blood pressure rise [13, 22]. It seems
that the doses of CsA routinely used in children and
adolescents are probably too low to have
a significant detrimental effect on autonomic
nervous system activity [12]. Cyclosporine A
nephrotoxicity depends on its vasoconstricting
effect on afferent glomerular arterioles [7]. It was
found that CsA decreased mRNA synthesis of nitric
oxide synthase in rodents and induced direct
endothelial damage [25]. These mechanisms might
be responsible for CsA-induced hypertension. In our
study group we had 5 children (26%) with
hypertension, when in other studies the percentage
of hypertensive children among CsA-treated
patients varied from 10% to 12% [1]. Perhaps this
increase may be related to longer CsA treatment
(44 m vs. 34 or 22 in other studies) [1].
Many non-invasive techniques have been
developed to measure arterial and peripheral blood
flow in humans. The thermographic methods
applied in our study were less invasive than
ultrasound brachial artery relaxation in response to
transient ischaemia applied in adult patients [26].
Thermography has become a standard indirect
measurement in diagnosis of RP as painless and
easily analysed [14]. It was observed that the
changes in superficial hand temperature correlated
positively with small vessel reactivity and
furthermore might be applied to assess endothelial
dysfunction [27]. 
Our study, however, has some limitations. The
number of studied patients was relatively small,
and drawing unequivocal conclusions from our
experiment would be premature. Moreover, we
have not studied children with NS but not treated
with CsA, which if we had would have enabled us
to precisely discern between the vascular damaging
impact of NS and CsA treatment. However, one
reason for that was the fact that at our centre
nowadays few children with steroid-dependent
(similar by clinical classification) NS are not treated
with CsA. We tried to reduce this bias by qualifyingArch Med Sci 4, August / 2010 577
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children with low dose steroid treatment, but it
should be strongly taken into consideration in the
clinical interpretation and should force further
detailed investigation. Other drugs with a proven
influence on endo  thelium and sympathetic activity
were excluded (β-blockers, ACE inhibitors).
In conclusion, the results of our study suggest
that in children with nephrotic syndrome treated
with CsA administered in low doses small vessel
dysfunction as measured with the novel and
valuable thermographic method is detected. This
effect seems to be independent of sympathetic
nervous system involvement, which was absent in
cyclosporine A treated nephrotic children. 
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